BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31100944)

  • 1. Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Effects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis.
    Chiu SP; Batsaikhan B; Huang HM; Wang JY
    Sensors (Basel); 2019 May; 19(10):. PubMed ID: 31100944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism of 4HPR and SAHA increases anti-tumor actions in glioblastoma cells.
    Khathayer F; Taylor MA; Ray SK
    Apoptosis; 2020 Apr; 25(3-4):217-232. PubMed ID: 32006189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
    Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
    J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
    Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
    Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide.
    Su YK; Bamodu OA; Tzeng YM; Hsiao M; Yeh CT; Lin CM
    Phytomedicine; 2019 Aug; 61():152840. PubMed ID: 31035045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas.
    Gonçalves RM; Agnes JP; Delgobo M; de Souza PO; Thomé MP; Heimfarth L; Lenz G; Moreira JCF; Zanotto-Filho A
    Biochem Pharmacol; 2019 May; 163():440-450. PubMed ID: 30878553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells.
    Li Y; Zhang P; Qiu F; Chen L; Miao C; Li J; Xiao W; Ma E
    Life Sci; 2012 Jun; 90(25-26):962-7. PubMed ID: 22634579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro and structural aspects of cap substituted Suberoylanilide hydroxamic acid analogs as potential inducers of apoptosis in Glioblastoma cancer cells via HDAC /microRNA regulation.
    Mekala JR; Ramalingam PS; Mathavan S; Yamajala RBRD; Moparthi NR; Kurappalli RK; Manyam RR
    Chem Biol Interact; 2022 Apr; 357():109876. PubMed ID: 35283086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
    Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
    Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug.
    Chen J; Luo B; Wen S; Pi R
    Invest New Drugs; 2020 Jun; 38(3):755-764. PubMed ID: 31414267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
    Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
    Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.
    Duncan HF; Smith AJ; Fleming GJ; Partridge NC; Shimizu E; Moran GP; Cooper PR
    J Cell Physiol; 2016 Apr; 231(4):798-816. PubMed ID: 26264761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
    Qiu X; Rong X; Yang J; Lu Y
    BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.
    Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC
    Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
    Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
    Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andrographolide Inhibits Proliferation and Metastasis of SGC7901 Gastric Cancer Cells.
    Dai L; Wang G; Pan W
    Biomed Res Int; 2017; 2017():6242103. PubMed ID: 28194420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility.
    Zhao HF; Wang G; Wu CP; Zhou XM; Wang J; Chen ZP; To ST; Li WP
    CNS Neurol Disord Drug Targets; 2018; 17(7):557-567. PubMed ID: 29886836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low‑grade glioma.
    Zhou L; Tang H; Wang F; Ou S; Wu T; Fang Y; Xu J; Guo K
    Oncol Rep; 2020 Mar; 43(3):807-816. PubMed ID: 32020219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.